Centene Other — Segment gross margin increased by 62.2% to $120.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.1%, from $110.00M to $120.00M. Over 4 years (FY 2021 to FY 2025), Other — Segment gross margin shows a downward trend with a -17.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher margins indicate better pricing power or effective cost control within the segment's operations.
Measures the profitability of the 'Other' segment by subtracting medical costs and cost of services from the segment's t...
Comparable to 'Segment Operating Income' or 'Gross Profit' in other healthcare business segments.
cnc_segment_other_segment_gross_margin| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $229.50M | $229.50M | $229.50M | $491.00M | $489.00M | $377.00M | $376.00M | $316.00M | $309.00M | $288.00M | $187.00M | $175.00M | $155.00M | $120.00M | $115.00M | $110.00M | $92.00M | $159.00M | $74.00M | $120.00M |
| QoQ Change | — | +0.0% | +0.0% | +113.9% | -0.4% | -22.9% | -0.3% | -16.0% | -2.2% | -6.8% | -35.1% | -6.4% | -11.4% | -22.6% | -4.2% | -4.3% | -16.4% | +72.8% | -53.5% | +62.2% |
| YoY Change | — | — | — | — | +113.1% | +64.3% | +63.8% | -35.6% | -36.8% | -23.6% | -50.3% | -44.6% | -49.8% | -58.3% | -38.5% | -37.1% | -40.6% | +32.5% | -35.7% | +9.1% |